Atara Biotherapeutics Market Sentiment

SPY764.38+0.23%QQQ744.05+0.58%BTC/USD83,799.00+0.29%DIA508.08−0.09%GLD381.59+0.20%TLT77.25−0.28%

Atara Biotherapeutics Inc

ATRANASDAQ

Trade with Public

$8.50

0.455.59%

Last update: Sep 30, 8:13 AM

$8.83

0.789.69%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Stock Report

Atara Biotherapeutics Market Sentiment - Benzinga

Atara Biotherapeutics Market Sentiment

Market sentiment signals for Atara Biotherapeutics (ATRA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 5.5% short float

Options Flow— N/A

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

8 analysts

Options Flow (P/C)

—

Avg Consensus PT

$22

+153.9%

Highest Price Target

$58

+551.2%

Stifel

Lowest Price Target

$10

+13.3%

Freedom Broker

Short Interest

5.5%

Declining — Bullish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
May 18, 2026	Freedom Broker	Ilya Zubkov—	+13.3%	$4 → $10	Upgrade	Sell→Hold
May 8, 2026	Canaccord Genuity	John Newman—	+47.2%	$6 → $13	Upgrade	Hold→Buy
Jan 21, 2026	Freedom Broker	Ilya Zubkov—	-54.7%	$16 → $4	Downgrade	Buy→Sell
Jan 13, 2026	Canaccord Genuity	John Newman—	-32.0%	$25 → $6	Downgrade	Buy→Hold
Dec 19, 2025	Canaccord Genuity	John Newman—	+183.1%	$17 → $25	Maintained	Buy
Jul 28, 2025	Freedom Broker	Ilya Zubkov—	+81.2%	$13 → $16	Maintained	Sell
May 23, 2025	Freedom Broker	Ilya Zubkov—	+47.2%	$11 → $13	Maintained	Sell
Mar 13, 2025	Freedom Broker	Ilya Zubkov—	+24.6%	$13 → $11	Maintained	Sell
Mar 11, 2025	Canaccord Genuity	John Newman—	+92.5%	$17 → $17	Maintained	Buy
Jan 28, 2025	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Jan 22, 2025	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Jan 17, 2025	Canaccord Genuity	John Newman—	+92.5%	$21 → $17	Maintained	Buy
Dec 20, 2024	Rodman & Renshaw	Tony Butler—	+183.1%	$25	Initiate	Buy
Nov 13, 2024	Canaccord Genuity	John Newman—	+137.8%	$13 → $21	Maintained	Buy
Aug 21, 2024	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Aug 16, 2024	Mizuho	Salim Syed—	+103.9%	$25 → $18	Upgrade	Neutral→Outperform
Aug 13, 2024	Canaccord Genuity	John Newman—	+47.2%	$13 → $13	Maintained	Buy
Jul 17, 2024	Goldman Sachs	Tommie Reerink—	+24.6%	$13 → $11	Maintained	Sell
May 22, 2024	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Apr 1, 2024	Stifel	Benjamin Burnett—	-74.0%	$5 → $2	Maintained	Hold
Nov 10, 2023	Goldman Sachs	Tommie Reerink—	-94.3%	$3 → $1	Maintained	Sell
Nov 9, 2023	Evercore ISI Group	Michael DiFiore—	—	—	Downgrade	Outperform→In-Line
Nov 9, 2023	HC Wainwright & Co.	Robert Burns—	—	—	Downgrade	Buy→Neutral
Nov 9, 2023	Mizuho	Salim Syed—	-88.7%	$31 → $1	Downgrade	Buy→Neutral